Ranibizumab for neovascular age-related macular degeneration.

Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, MARINA Study Group

DOI: 10.1056/nejmoa054481
Published: 2006 Oct 5
Container: The New England journal of medicine
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa054481,
  title = {Ranibizumab for neovascular age-related macular degeneration.},
  author = {Rosenfeld PJ and Brown DM and Heier JS and Boyer DS and Kaiser PK and Chung CY and Kim RY and MARINA Study Group},
  year = {2006},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa054481},
  url = {https://doi.org/10.1056/nejmoa054481}
}

RIS

TY  - JOUR
TI  - Ranibizumab for neovascular age-related macular degeneration.
AU  - Rosenfeld PJ
AU  - Brown DM
AU  - Heier JS
AU  - Boyer DS
AU  - Kaiser PK
AU  - Chung CY
AU  - Kim RY
AU  - MARINA Study Group
PY  - 2006
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa054481
UR  - https://doi.org/10.1056/nejmoa054481
ER  -

APA

PJ, R., DM, B., JS, H., DS, B., PK, K., CY, C., RY, K., & Group, M. S. (2006). Ranibizumab for neovascular age-related macular degeneration.. The New England journal of medicine. https://doi.org/10.1056/nejmoa054481

Source records

pubmed · retrieved 2026-11-10T07:57:25.411Z
europe-pmc · retrieved 2026-11-10T07:57:25.426Z